The Cooper Companies, Inc. (NASDAQ:COO) is among the 11 Most Oversold Stocks to Buy Now.
On March 6, 2026, Needham raised its price target on The Cooper Companies, Inc. (NASDAQ:COO) to $101 from $99 and maintained a Buy rating. Needham said the company’s Q1 results marked a solid start to the year, noting improving end markets and operating efficiencies that have supported margin expansion and earnings upside.
Also on March 6, Barclays raised its price target on Cooper Companies to $103 from $98 and kept an Overweight rating. Barclays said the company delivered improving sequential growth in its Vision and Surgical segments, which helped offset declines in older, lower-margin hydrogel products in Japan. The firm added that the shares appear attractive at current levels.
On March 5, 2026, Cooper Companies reported Q1 non-GAAP EPS of $1.10, above the $1.03 consensus estimate, with revenue of $1.024B compared with the $1.02B consensus. CEO Al White said the company delivered “a strong start to the fiscal year,” supported by product launches, profitability, and robust cash flow. White also highlighted growth in the premium MyDay portfolio and early traction from MyDay MiSight, while operating margins exceeded expectations due to efficiencies and synergies from last year’s reorganization.
The Cooper Companies, Inc. (NASDAQ:COO) develops, manufactures, and markets products for contact lens wearers through its CooperVision and CooperSurgical segments.
While we acknowledge the potential of COO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026
Disclosure: None. Follow Insider Monkey on Google News.
